Search Results - "Schiller, H"

The MERIS Case 2 water algorithm by Doerffer, R., Schiller, H.

“…The paper describes the case 2 coastal water algorithm, which has been developed for the ground processor of the Medium Resolution Imaging Spectrometer…”
Get full text

Parallel information processing channels created in the retina by Schiller, Peter H.

“…In the retina, several parallel channels originate that extract different attributes from the visual scene. This review describes how these channels arise and…”
Get full text

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update by Hanna, Nasser, Johnson, David, Temin, Sarah, Baker, Jr, Sherman, Brahmer, Julie, Ellis, Peter M, Giaccone, Giuseppe, Hesketh, Paul J, Jaiyesimi, Ishmael, Leighl, Natasha B, Riely, Gregory J, Schiller, Joan H, Schneider, Bryan J, Smith, Thomas J, Tashbar, Joan, Biermann, William A, Masters, Gregory

“…Purpose Provide evidence-based recommendations updating the 2015 ASCO guideline on systemic therapy for patients with stage IV non-small-cell lung cancer…”
Get full text

Maintenance Chemotherapy for Advanced Non–Small-Cell Lung Cancer: New Life for an Old Idea by Gerber, David E, Schiller, Joan H

“…Although well established for the treatment of certain hematologic malignancies, maintenance therapy has only recently become a treatment paradigm for advanced…”
Get full text

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update by Hanna, Nasser H, Schneider, Bryan J, Temin, Sarah, Baker, Jr, Sherman, Brahmer, Julie, Ellis, Peter M, Gaspar, Laurie E, Haddad, Rami Y, Hesketh, Paul J, Jain, Dharamvir, Jaiyesimi, Ishmael, Johnson, David H, Leighl, Natasha B, Phillips, Tanyanika, Riely, Gregory J, Robinson, Andrew G, Rosell, Rafael, Schiller, Joan H, Singh, Navneet, Spigel, David R, Stabler, Janis O, Tashbar, Joan, Masters, Gregory

“…The aim of this work is to provide evidence-based recommendations updating the 2017 ASCO guideline on systemic therapy for patients with stage IV…”
Get full text

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update by Masters, Gregory A, Temin, Sarah, Azzoli, Christopher G, Giaccone, Giuseppe, Baker, Jr, Sherman, Brahmer, Julie R, Ellis, Peter M, Gajra, Ajeet, Rackear, Nancy, Schiller, Joan H, Smith, Thomas J, Strawn, John R, Trent, David, Johnson, David H

“…To provide evidence-based recommendations to update the American Society of Clinical Oncology guideline on systemic therapy for stage IV non-small-cell lung…”
Get full text

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline by Singh, Navneet, Temin, Sarah, Baker, Jr, Sherman, Blanchard, Elizabeth, Brahmer, Julie R, Celano, Paul, Duma, Narjust, Ellis, Peter M, Elkins, Ivy B, Haddad, Rami Y, Hesketh, Paul J, Jain, Dharamvir, Johnson, David H, Leighl, Natasha B, Mamdani, Hirva, Masters, Gregory, Moffitt, Pamela R, Phillips, Tanyanika, Riely, Gregory J, Robinson, Andrew G, Rosell, Rafael, Schiller, Joan H, Schneider, Bryan J, Spigel, David R, Jaiyesimi, Ishmael A

“…To provide evidence-based recommendations updating the 2020 ASCO and Ontario Health (Cancer Care Ontario) guideline on systemic therapy for patients with stage…”
Get full text

American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer by Christopher G. Azzoli, Sherman Baker, Jr, Sarah Temin, William Pao, Timothy Aliff, Julie Brahmer, David H. Johnson, Janessa L. Laskin, Gregory Masters, Daniel Milton, Luke Nordquist, David G. Pfister, Steven Piantadosi, Joan H. Schiller, Reily Smith, Thomas J. Smith, John R. Strawn, David Trent, Giuseppe Giaccone

“…The purpose of this article is to provide updated recommendations for the treatment of patients with stage IV non-small-cell lung cancer. A literature search…”
Get full text

Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line Treatment of Advanced Non–Small-Cell Lung Cancer: An Individual Patient Data Meta-analysis by Ardizzoni, Andrea, Boni, Luca, Tiseo, Marcello, Fossella, Frank V., Schiller, Joan H., Paesmans, Marianne, Radosavljevic, Davorin, Paccagnella, Adriano, Zatloukal, Petr, Mazzanti, Paola, Bisset, Donald, Rosell, Rafael

“…Background Because the efficacy of carboplatin and cisplatin in the treatment of advanced non–small-cell lung cancer (NSCLC) has not been proven to be…”
Get full text

Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non–Small-Cell Lung Cancer by SEQUIST, Lecia V, VON PAWEL, Joachim, RAMLAU, Rodryg, ARTHUR, Susan, GORBACHEVSKY, Igor, SCHWARTZ, Brian, SCHILLER, Joan H, GARMEY, Edward G, AKERLEY, Wallace L, BRUGGER, Wolfram, FERRARI, Dora, YINPU CHEN, COSTA, Daniel B, GERBER, David E, ORLOV, Sergey

“…c-MET (MET) receptor activation is associated with poor prognosis and epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) resistance in…”
Get full text

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer by AZZOLI, Christopher G, TEMIN, Sarah, PAO, William, PFISTER, David G, PIANTADOSI, Steven, SCHILLER, Joan H, SMITH, Reily, SMITH, Thomas J, STRAWN, John R, TRENT, David, GIACCONE, Giuseppe, ALIFF, Timothy, BAKER, Sherman, BRAHMER, Julie, JOHNSON, David H, LASKIN, Janessa L, MASTERS, Gregory, MILTON, Daniel, NORDQUIST, Luke

“…An American Society of Clinical Oncology (ASCO) focused update updates a single recommendation (or subset of recommendations) in advance of a regularly…”
Get full text

Cell Adhesion Molecules, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor in Patients with Non–Small Cell Lung Cancer Treated with Chemotherapy with or without Bevacizumab—an Eastern Cooperative Oncology Group Study by Dowlati, Afshin, Gray, Robert, Sandler, Alan B, Schiller, Joan H, Johnson, David H

“…Background: E4599 was a phase II/phase III trial, in which 878 patients with advanced non–small cell lung cancer were randomized to carboplatin + paclitaxel…”
Get full text

Collaboration in interprofessional teams: A needs assessment of factors that impact new resident physicians by B. Allen, Brittany, H. Schiller, Jocelyn, J. Roberts, Suni, G. Allen, Steven, K. Morgan, Helen, Malone, Anita

“…Many resident physicians struggle with effective interprofessional collaboration (IPC), but characterization of their challenges is not well known. This study…”
Get full text

New molecularly targeted therapies for lung cancer by Sun, Sophie, Schiller, Joan H, Spinola, Monica, Minna, John D

“…Lung cancer is the leading cause of cancer death worldwide. The disease is particularly difficult to detect, and patients often present at an advanced stage…”
Get full text

Clinical Course of Advanced Non–Small-Cell Lung Cancer Patients Experiencing Hypertension During Treatment With Bevacizumab in Combination With Carboplatin and Paclitaxel on ECOG 4599 by DAHLBERG, Suzanne E, SANDLER, Alan B, BRAHMER, Julie R, SCHILLER, Joan H, JOHNSON, David H

“…PURPOSE Bevacizumab is a monoclonal antibody that targets vascular endothelial growth factor (VEGF) with demonstrated efficacy in combination with carboplatin…”
Get full text

Phase III Study of Immediate Compared With Delayed Docetaxel After Front-Line Therapy With Gemcitabine Plus Carboplatin in Advanced Non–Small-Cell Lung Cancer by FIDIAS, Panos M, DAKHIL, Shaker R, MARCINIAK, Martin, GILL, John, SCHILLER, Joan H, LYSS, Alan P, LOESCH, David M, WATERHOUSE, David M, BROMUND, Jane L, RUQIN CHEN, HRISTOVA-KAZMIERSKI, Maria, TREAT, Joseph, OBASAJU, Coleman K

“…Gemcitabine plus carboplatin (GC) is active as front-line treatment for advanced non-small-cell lung cancer (NSCLC). For patients without progression, timing…”
Get full text

Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer by Schiller, Joan H, Harrington, David, Belani, Chandra P, Langer, Corey, Sandler, Alan, Krook, James, Zhu, Junming, Johnson, David H

“…Four combinations of chemotherapy were compared in patients with advanced non–small-cell lung cancer. No one regimen appeared to be superior to the others. The…”
Get full text

Chemical components separation with botulinum toxin A: a novel technique to improve primary fascial closure rates of the open abdomen by Zielinski, M. D., Goussous, N., Schiller, H. J., Jenkins, D.

“…Introduction Failure to definitively close the open abdomen (OA) after damage control laparotomy leads to considerable morbidity and mortality. We have…”
Get full text

Outcomes for Elderly, Advanced-Stage Non–Small-Cell Lung Cancer Patients Treated With Bevacizumab in Combination With Carboplatin and Paclitaxel: Analysis of Eastern Cooperative Oncology Group Trial 4599 by RAMALINGAM, Suresh S, DAHLBERG, Suzanne E, LANGER, Corey J, GRAY, Robert, BELANI, Chandra P, BRAHMER, Julie R, SANDLER, Alan B, SCHILLER, Joan H, JOHNSON, David H

“…Fit elderly patients with advanced non-small-cell lung cancer (NSCLC) benefit from platinum-based, two-drug chemotherapy. Bevacizumab (B) in combination with…”
Get full text

Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2 by HERBST, Roy S, GIACCONE, Giuseppe, WOLF, Michael K, KREBS, Annetta D, AVERBUCH, Steven D, OCHS, Judith S, GROUS, John, FANDI, Abderrahim, JOHNSON, David H, SCHILLER, Joan H, NATALE, Ronald B, MILLER, Vincent, MANEGOLD, Christian, SCAGLIOTTI, Giorgio, ROSELL, Rafael, OLIFF, Ira, REEVES, James A

“…Preclinical studies indicate that gefitinib (Iressa, ZD1839; AstraZeneca, Wilmington, DE), an orally active epidermal growth factor receptor tyrosine kinase…”
Get full text